<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="7fa41601-7fb5-4155-8e50-2ae903f0d2d6"><labelDrug name="Multaq"><Normalization><mmtx cui="C1744304" preferredWord="Multaq" semType="phsu, orch"/></Normalization></labelDrug><generic name="Dronedarone"/><sentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.1" text="MULTAQ (dronedarone) tablet, film coated" type="negative"><entity charOffset="0:6" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.1.e.0" text="multaq" type="Biomedical_Entity"><Normalization><mmtx cui="C1744304" phraseText="MULTAQ" preferredWord="Multaq" semType="phsu, orch"/><RxNorm RxCui="677229"/></Normalization></entity><entity charOffset="8:19" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.1.e.1" text="dronedarone" type="Biomedical_Entity"><Normalization><mmtx cui="C0766326" phraseText="(dronedarone" preferredWord="dronedarone" semType="phsu, orch"/><RxNorm RxCui="233698"/></Normalization></entity><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.1.e.0" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.1.e.1"/></sentence><sentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.2" text="Dronedarone HCl is a white fine powder that is practically insoluble in water and freely soluble in methylene chloride and methanol." type="negative"><entity charOffset="0:11" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.2.e.0" text="dronedarone" type="Biomedical_Entity"><Normalization><mmtx cui="C0766326" phraseText="Dronedarone HCl" preferredWord="dronedarone" semType="phsu, orch"/><RxNorm RxCui="233698"/></Normalization></entity><entity charOffset="100:118" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.2.e.1" text="methylene chloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0025748" phraseText="freely soluble in methylene chloride" preferredWord="methylene chloride" semType="phsu, orch, hops"/><RxNorm RxCui="1311537"/></Normalization></entity><entity charOffset="123:131" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.2.e.2" text="methanol" type="Biomedical_Entity"><Normalization><mmtx cui="C0001963" phraseText="methanol." preferredWord="Methanol" semType="phsu, orch, hops"/><RxNorm RxCui="1310568"/></Normalization></entity><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.2.e.0" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.2.e.1"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.2.e.0" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.2.e.2"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.2.e.1" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.2.e.2"/></sentence><sentence biomedicalEntities="1" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.4" lineNumber="7" text="MULTAQ is contraindicated in patients with:" type="regular"><entity charOffset="10:25" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.4.e.0" text="contraindicated" type="Caution_Interaction"/><entity charOffset="10:25" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.4.e.2" text="contraindicated" type="SPAN"/><entity charOffset="0:6" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.4.e.3" text="MULTAQ" type="Drug"><Normalization><mmtx cui="C1744304" phraseText="MULTAQ" preferredWord="Multaq" semType="phsu, orch"/><RxNorm RxCui="677229"/></Normalization></entity><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.4.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.4.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.10.e.0"/></relation><relation type="hasSeverity"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.4.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.4.e.3"/></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9" text="Concomitant use of strong CYP 3A inhibitors, such as ketoconazole, itraconazole, voriconazole, cyclosporine, telithromycin, clarithromycin, nefazodone, and ritonavir [see Drug Interactions (7.2)]" type="negative"><entity charOffset="156:165" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.0" text="ritonavir" type="Biomedical_Entity"><Normalization><mmtx cui="C0292818" phraseText="ritonavir" preferredWord="Ritonavir" semType="phsu, orch"/><RxNorm RxCui="85762"/></Normalization></entity><entity charOffset="140:150" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.1" text="nefazodone" type="Biomedical_Entity"><Normalization><mmtx cui="C0068485" phraseText="nefazodone," preferredWord="nefazodone" semType="phsu, orch"/><RxNorm RxCui="31565"/></Normalization></entity><entity charOffset="81:93" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.2" text="voriconazole" type="Biomedical_Entity"><Normalization><mmtx cui="C0393080" phraseText="voriconazole," preferredWord="voriconazole" semType="phsu, orch"/><RxNorm RxCui="121243"/></Normalization></entity><entity charOffset="124:138" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.3" text="clarithromycin" type="Biomedical_Entity"><Normalization><mmtx cui="C0055856" phraseText="clarithromycin," preferredWord="Clarithromycin" semType="orch, antb"/><RxNorm RxCui="21212"/></Normalization></entity><entity charOffset="109:122" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.4" text="telithromycin" type="Biomedical_Entity"><Normalization><mmtx cui="C0907410" phraseText="telithromycin," preferredWord="telithromycin" semType="orch, antb"/><RxNorm RxCui="274786"/></Normalization></entity><entity charOffset="67:79" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.5" text="itraconazole" type="Biomedical_Entity"><Normalization><mmtx cui="C0064113" phraseText="itraconazole," preferredWord="Itraconazole" semType="phsu, orch"/><RxNorm RxCui="28031"/></Normalization></entity><entity charOffset="53:65" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.6" text="ketoconazole" type="Biomedical_Entity"><Normalization><mmtx cui="C0022625" phraseText="such as ketoconazole," preferredWord="Ketoconazole" semType="phsu, orch"/><RxNorm RxCui="6135"/></Normalization></entity><entity charOffset="95:107" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.7" text="cyclosporine" type="Biomedical_Entity"><Normalization><mmtx cui="C0010592" phraseText="cyclosporine," preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.1" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.0"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.2" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.0"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.3" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.0"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.4" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.0"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.5" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.0"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.6" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.0"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.7" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.0"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.2" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.1"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.3" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.1"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.4" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.1"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.5" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.1"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.6" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.1"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.7" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.1"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.2" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.3"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.2" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.4"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.5" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.2"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.6" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.2"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.2" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.7"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.4" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.3"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.5" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.3"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.6" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.3"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.7" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.3"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.5" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.4"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.6" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.4"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.7" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.4"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.6" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.5"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.5" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.7"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.6" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9.e.7"/></sentence><sentence biomedicalEntities="5" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.10" lineNumber="14" text="Concomitant use of drugs or herbal products that prolong the QT interval and might increase the risk of Torsade de Pointes, such as phenothiazine anti-psychotics, tricyclic antidepressants, certain oral macrolide antibiotics, and Class I and III antiarrhythmics" type="irregular"><entity charOffset="19:72" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.10.e.0" text="drugs or herbal products that prolong the QT interval" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="Concomitant use of drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="132:161" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.10.e.1" text="phenothiazine anti-psychotics" type="Drug_Class"><Normalization><mmtx cui="C0031434" phraseText="such as phenothiazine anti-psychotics," preferredWord="phenothiazine" semType="phsu, orch"/><mmtx cui="C3536886" phraseText="such as phenothiazine anti-psychotics," preferredWord="Phenothiazine [EPC]" semType="phsu"/><RxNorm RxCui="1437064"/></Normalization></entity><entity charOffset="163:188" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.10.e.2" text="tricyclic antidepressants" type="Drug_Class"><Normalization><mmtx cui="C0003290" phraseText="tricyclic antidepressants," preferredWord="Tricyclic Antidepressive Agents" semType="phsu"/><RxNorm RxCui="928"/></Normalization></entity><entity charOffset="198:224" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.10.e.3" text="oral macrolide antibiotics" type="Drug_Class"><Normalization><mmtx cui="C0003240" phraseText="certain oral macrolide antibiotics," preferredWord="Macrolide Antibiotics" semType="orch, antb"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="230:261" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.10.e.4" text="Class I and III antiarrhythmics" type="Drug_Class"><Normalization><mmtx cui="C0003195" phraseText="III antiarrhythmics" preferredWord="Anti-Arrhythmia Agents" semType="phsu"/><RxNorm RxCui="5716"/></Normalization></entity><entity charOffset="104:122" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.10.e.9" text="Torsade de Pointes" type="Specific_Interaction"><Normalization><mmtx cui="C0040479" phraseText="the risk of Torsade de Pointes," preferredWord="Torsades de Pointes" semType="dsyn"/></Normalization></entity><classClassMembership drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.10.e.1"/><classClassMembership drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.10.e.2"/><classClassMembership drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.10.e.3"/><classClassMembership drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.10.e.4"/><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.10.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.10.e.9"><relations><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.10.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.4" text="MULTAQ is contraindicated in patients with:"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.4.e.3"/></ellipsisSentence><middleSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.5" text="Permanent atrial fibrillation (patients in whom normal sinus rhythm will not or cannot be restored) [see Boxed Warning and Warnings and Precautions (5.2)]"/><middleSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.6" text="Symptomatic heart failure with recent decompensation requiring hospitalization or NYHA Class IV symptoms [see Boxed Warning and Warnings and Precautions (5.1)]"/><middleSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.7" text="Second- or third-degree atrioventricular (AV) block, or sick sinus syndrome (except when used in conjunction with a functioning pacemaker)"/><middleSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.8" text="Bradycardia &lt;50 bpm"/><middleSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.9" text="Concomitant use of strong CYP 3A inhibitors, such as ketoconazole, itraconazole, voriconazole, cyclosporine, telithromycin, clarithromycin, nefazodone, and ritonavir [see Drug Interactions (7.2)]"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.10.e.0"/></sentence><sentence biomedicalEntities="1" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.47" lineNumber="52" text="Hypokalemia or hypomagnesemia may occur with concomitant administration of potassium-depleting diuretics. " type="irregular"><entity charOffset="75:104" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.47.e.0" text="potassium-depleting diuretics" type="Drug_Class"><Normalization><mmtx cui="C1563712" phraseText="occur with concomitant administration of potassium-depleting diuretics." preferredWord="Potassium Depleting Diuretics" semType="phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="0:11" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.47.e.1" text="Hypokalemia" type="Specific_Interaction"/><entity charOffset="15:29" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.47.e.3" text="hypomagnesemia" type="Specific_Interaction"/><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.47.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.47.e.1"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.45" text="If pulmonary toxicity is confirmed, MULTAQ should be discontinued."><entity charOffset="36:42" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.45.e.0" text="MULTAQ" type="Drug"><Normalization><mmtx cui="C1744304" phraseText="MULTAQ" preferredWord="Multaq" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.46" text="5.7 Hypokalemia and Hypomagnesemia with Potassium-Depleting Diuretics"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.47.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.47.ddi.2"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.47.e.3"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.45" text="If pulmonary toxicity is confirmed, MULTAQ should be discontinued."><entity charOffset="36:42" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.45.e.0" text="MULTAQ" type="Drug"><Normalization><mmtx cui="C1744304" phraseText="MULTAQ" preferredWord="Multaq" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.46" text="5.7 Hypokalemia and Hypomagnesemia with Potassium-Depleting Diuretics"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.47.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.47.e.0"/></sentence><sentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.48" text="Potassium levels should be within the normal range prior to administration of MULTAQ and maintained in the normal range during administration of MULTAQ." type="negative"><entity charOffset="78:84" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.48.e.0" text="multaq" type="Biomedical_Entity"><Normalization><mmtx cui="C1744304" phraseText="of MULTAQ" preferredWord="Multaq" semType="phsu, orch"/><RxNorm RxCui="677229"/></Normalization></entity><entity charOffset="145:151" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.48.e.1" text="multaq" type="Biomedical_Entity"><Normalization><mmtx cui="C1744304" phraseText="of MULTAQ." preferredWord="Multaq" semType="phsu, orch"/><RxNorm RxCui="677229"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.48.e.2" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="Potassium levels" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.48.e.2" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.48.e.0"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.48.e.2" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.48.e.1"/></sentence><sentence biomedicalEntities="5" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.66" lineNumber="76" text="Co-administration of drugs prolonging the QT interval (such as certain phenothiazines, tricyclic antidepressants, certain macrolide antibiotics, and Class I and III antiarrhythmics) is contraindicated because of the potential risk of Torsade de Pointes-type ventricular tachycardia [see Contraindications (4), Clinical Pharmacology (12.3)]." type="irregular"><entity charOffset="21:53" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.66.e.0" text="drugs prolonging the QT interval" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="Co-administration of drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="185:200" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.66.e.1" text="contraindicated" type="Caution_Interaction"/><entity charOffset="185:200" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.66.e.3" text="contraindicated" type="SPAN"/><entity charOffset="234:281" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.66.e.4" text="Torsade de Pointes-type ventricular tachycardia" type="Specific_Interaction"><Normalization><mmtx cui="C0040479" phraseText="contraindicated because of the potential risk of Torsade de Pointes-type ventricular tachycardia" preferredWord="Torsades de Pointes" semType="dsyn"/></Normalization></entity><entity charOffset="71:85" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.66.e.6" text="phenothiazines" type="Drug_Class"><Normalization><mmtx cui="C0031434" phraseText="such as certain phenothiazines," preferredWord="phenothiazine" semType="phsu, orch"/><mmtx cui="C0031436" phraseText="such as certain phenothiazines," preferredWord="Phenothiazines" semType="phsu, orch"/><mmtx cui="C0304370" phraseText="such as certain phenothiazines," preferredWord="Phenothiazine derivatives" semType="phsu, orch"/><RxNorm RxCui="1437064"/></Normalization></entity><entity charOffset="87:112" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.66.e.7" text="tricyclic antidepressants" type="Drug_Class"><Normalization><mmtx cui="C0003290" phraseText="tricyclic antidepressants," preferredWord="Tricyclic Antidepressive Agents" semType="phsu"/><RxNorm RxCui="928"/></Normalization></entity><entity charOffset="122:143" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.66.e.8" text="macrolide antibiotics" type="Drug_Class"><Normalization><mmtx cui="C0003240" phraseText="certain macrolide antibiotics," preferredWord="Macrolide Antibiotics" semType="orch, antb"/><RxNorm RxCui="1437086"/></Normalization></entity><entity charOffset="149:180" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.66.e.9" text="Class I and III antiarrhythmics" type="Drug_Class"><Normalization><mmtx cui="C0003195" phraseText="III antiarrhythmics" preferredWord="Anti-Arrhythmia Agents" semType="phsu"/><RxNorm RxCui="5716"/></Normalization></entity><classClassMembership drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.66.e.6"/><classClassMembership drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.66.e.7"/><classClassMembership drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.66.e.8"/><classClassMembership drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.66.e.9"/><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.66.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.66.e.1"><relations><relation type="hasSeverity"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.66.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.66.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.60" text="Premenopausal women who have not undergone a hysterectomy or oophorectomy must use effective contraception while using MULTAQ. "><entity charOffset="119:125" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.60.e.0" text="MULTAQ" type="Drug"><Normalization><mmtx cui="C1744304" phraseText="MULTAQ." preferredWord="Multaq" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.61" text="Dronedarone caused fetal harm in animal studies at doses equivalent to recommended human doses. "/><middleSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.62" text="Counsel women of childbearing potential regarding appropriate contraceptive choices [see Use in Specific Populations (8.1)]."/><middleSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.63" text="7 DRUG INTERACTIONS"/><middleSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.64" text="7.1 Pharmacodynamic Interactions"/><middleSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.65" text="Drugs prolonging the QT interval (inducing Torsade de Pointes)"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.66.ddi.2"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.66.e.4"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.60" text="Premenopausal women who have not undergone a hysterectomy or oophorectomy must use effective contraception while using MULTAQ. "><entity charOffset="119:125" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.60.e.0" text="MULTAQ" type="Drug"><Normalization><mmtx cui="C1744304" phraseText="MULTAQ." preferredWord="Multaq" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.61" text="Dronedarone caused fetal harm in animal studies at doses equivalent to recommended human doses. "/><middleSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.62" text="Counsel women of childbearing potential regarding appropriate contraceptive choices [see Use in Specific Populations (8.1)]."/><middleSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.63" text="7 DRUG INTERACTIONS"/><middleSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.64" text="7.1 Pharmacodynamic Interactions"/><middleSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.65" text="Drugs prolonging the QT interval (inducing Torsade de Pointes)"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.66.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.66.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.68" lineNumber="80" text="In the ANDROMEDA (patients with recently decompensated heart failure) and PALLAS (patients with permanent AF) trials baseline use of digoxin was associated with an increased risk of arrhythmic or sudden death in dronedarone-treated patients compared to placebo. " type="regular"><entity charOffset="7:69|110:116" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.68.e.0" text="ANDROMEDA (patients with recently decompensated heart failure) trials" type="SPAN"><Normalization><mmtx cui="C0018801" phraseText="(patients with recently decompensated heart failure" preferredWord="Heart failure" semType="dsyn"/><mmtx cui="C0018802" phraseText="(patients with recently decompensated heart failure" preferredWord="Congestive heart failure" semType="dsyn"/></Normalization></entity><entity charOffset="74:116" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.68.e.1" text="PALLAS (patients with permanent AF) trials" type="SPAN"/><entity charOffset="133:140" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.68.e.2" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="(patients with permanent AF) trials baseline use of digoxin" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="182:208" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.68.e.3" text="arrhythmic or sudden death" type="Specific_Interaction"/><entity charOffset="212:223" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.68.e.5" text="dronedarone" type="Drug"><Normalization><mmtx cui="C0766326" phraseText="sudden death in dronedarone-treated patients" preferredWord="dronedarone" semType="phsu, orch"/><RxNorm RxCui="233698"/></Normalization></entity><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.68.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.68.e.3"><relations><relation type="hasEvidence"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.68.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.68.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.68.e.2"/></relation><relation type="hasEvidence"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.68.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.68.e.2" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.68.e.5" evidence="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.68.e.1, Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.68.e.0" trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.68.e.3" type="Specific_Interaction"/></sentence><sentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.69" text="In patients not taking digoxin, no difference in risk of sudden death was observed in the dronedarone vs. placebo groups. " type="negative"><entity charOffset="23:30" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.69.e.0" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="digoxin," preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="90:101" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.69.e.1" text="dronedarone" type="Biomedical_Entity"><Normalization><mmtx cui="C0766326" phraseText="observed in the dronedarone" preferredWord="dronedarone" semType="phsu, orch"/><RxNorm RxCui="233698"/></Normalization></entity><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.69.e.0" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.69.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.71" lineNumber="82" text="Digoxin can potentiate the electrophysiologic effects of dronedarone (such as decreased AV-node conduction). " type="regular"><entity charOffset="0:7" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.71.e.0" text="Digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="Digoxin" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="12:53" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.71.e.1" text="potentiate the electrophysiologic effects" type="Specific_Interaction"/><entity charOffset="57:68" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.71.e.3" text="dronedarone" type="Drug"><Normalization><mmtx cui="C0766326" phraseText="the electrophysiologic effects of dronedarone" preferredWord="dronedarone" semType="phsu, orch"/><RxNorm RxCui="233698"/></Normalization></entity><entity charOffset="78:106" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.71.e.4" text="decreased AV-node conduction" type="Specific_Interaction"/><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.71.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.71.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.71.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.71.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.71.ddi.2"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.71.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.71.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.71.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.71.e.0" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.71.e.3" trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.71.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.72" lineNumber="82" text="Dronedarone increases exposure to digoxin [see Drug Interactions (7.3), Clinical Pharmacology (12.3)]." type="regular"><entity charOffset="0:11" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.72.e.0" text="Dronedarone" type="Drug"><Normalization><mmtx cui="C0766326" phraseText="Dronedarone" preferredWord="dronedarone" semType="phsu, orch"/><RxNorm RxCui="233698"/></Normalization></entity><entity charOffset="34:41" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.72.e.1" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="exposure to digoxin" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="12:30" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.72.e.2" text="increases exposure" type="Increase_Interaction"/><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.72.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.72.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.72.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.72.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.72.e.0" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.72.e.1" trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.72.e.2" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.73" lineNumber="84" text="Consider discontinuing digoxin. " type="irregular"><entity charOffset="9:22" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.73.e.0" text="discontinuing" type="Caution_Interaction"/><entity charOffset="23:30" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.73.e.2" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="discontinuing digoxin." preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.73.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.73.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.73.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.72" text="Dronedarone increases exposure to digoxin [see Drug Interactions (7.3), Clinical Pharmacology (12.3)]."><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.72.e.0"/></ellipsisSentence></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.73.e.2"/></sentence><sentence biomedicalEntities="1" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.74" lineNumber="84" text="If digoxin treatment is continued, halve the dose of digoxin, monitor serum levels closely, and observe for toxicity." type="irregular"><entity charOffset="35:49" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.74.e.0" text="halve the dose" type="Caution_Interaction"/><entity charOffset="53:60" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.74.e.2" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="the dose of digoxin," preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="62:69" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.74.e.3" text="monitor" type="Caution_Interaction"/><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.74.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.74.e.0"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.72" text="Dronedarone increases exposure to digoxin [see Drug Interactions (7.3), Clinical Pharmacology (12.3)]."><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.72.e.0"/></ellipsisSentence><middleSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.73" text="Consider discontinuing digoxin. "/></relation><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.74.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.74.ddi.2"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.74.e.3"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.72" text="Dronedarone increases exposure to digoxin [see Drug Interactions (7.3), Clinical Pharmacology (12.3)]."><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.72.e.0"/></ellipsisSentence><middleSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.73" text="Consider discontinuing digoxin. "/></relation><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.74.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.74.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.76" lineNumber="88" text="Calcium channel blockers with depressant effects on the sinus and AV nodes could potentiate dronedarone's effects on conduction." type="regular"><entity charOffset="0:74" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.76.e.0" text="Calcium channel blockers with depressant effects on the sinus and AV nodes" type="Drug_Class"><Normalization><mmtx cui="C0006684" phraseText="Calcium channel blockers with depressant effects" preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="92:103" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.76.e.1" text="dronedarone" type="Drug"><Normalization><mmtx cui="C0766326" phraseText="dronedarone's effects on conduction." preferredWord="dronedarone" semType="phsu, orch"/><RxNorm RxCui="233698"/></Normalization></entity><entity charOffset="81:91|106:127" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.76.e.2" text="potentiate effects on conduction" type="Specific_Interaction"/><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.76.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.76.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.76.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.76.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.76.e.0" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.76.e.1" trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.76.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.77" lineNumber="90" text="Give a low dose of calcium channel blockers initially and increase only after ECG verification of good tolerability [see Drug Interactions (7.3), Clinical Pharmacology (12.3)]." type="irregular"><entity charOffset="0:15" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.77.e.0" text="Give a low dose" type="Caution_Interaction"/><entity charOffset="19:43" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.77.e.2" text="calcium channel blockers" type="Drug_Class"><Normalization><mmtx cui="C0006684" phraseText="a low dose of calcium channel blockers initially" preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.77.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.77.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.76" text="Calcium channel blockers with depressant effects on the sinus and AV nodes could potentiate dronedarone's effects on conduction."><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.76.e.1"/></ellipsisSentence></relation><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.77.e.2"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.79" lineNumber="94" text="In clinical trials, bradycardia was more frequently observed when dronedarone was given in combination with beta-blockers." type="regular"><entity charOffset="20:31" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.79.e.0" text="bradycardia" type="Specific_Interaction"/><entity charOffset="66:77" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.79.e.2" text="dronedarone" type="Drug"><Normalization><mmtx cui="C0766326" phraseText="dronedarone" preferredWord="dronedarone" semType="phsu, orch"/><RxNorm RxCui="233698"/></Normalization></entity><entity charOffset="108:121" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.79.e.3" text="beta-blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="with beta-blockers." preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.79.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.79.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.79.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.79.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.79.e.2" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.79.e.3" trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.79.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.80" lineNumber="96" text="Give a low dose of beta-blockers initially, and increase only after ECG verification of good tolerability [see Drug Interactions (7.3), Clinical Pharmacology (12.3)]." type="irregular"><entity charOffset="0:15" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.80.e.0" text="Give a low dose" type="Caution_Interaction"/><entity charOffset="19:32" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.80.e.2" text="beta-blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="a low dose of beta-blockers initially," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.80.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.80.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.79" text="In clinical trials, bradycardia was more frequently observed when dronedarone was given in combination with beta-blockers."><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.79.e.2"/></ellipsisSentence></relation><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.80.e.2"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="8" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83" lineNumber="102" text="Concomitant use of ketoconazole as well as other potent CYP 3A inhibitors such as itraconazole, voriconazole, ritonavir, clarithromycin, and nefazodone is contraindicated because exposure to dronedarone is significantly increased [see Contraindications (4), Clinical Pharmacology (12.3)]." type="regular"><entity charOffset="19:31" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.0" text="ketoconazole" type="Drug"><Normalization><mmtx cui="C0022625" phraseText="Concomitant use of ketoconazole" preferredWord="Ketoconazole" semType="phsu, orch"/><RxNorm RxCui="6135"/></Normalization></entity><entity charOffset="49:73" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.1" text="potent CYP 3A inhibitors" type="Drug_Class"><Normalization><RxNorm RxCui="402226"/></Normalization></entity><entity charOffset="82:94" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.2" text="itraconazole" type="Drug"><Normalization><mmtx cui="C0064113" phraseText="other potent CYP 3A inhibitors such as itraconazole," preferredWord="Itraconazole" semType="phsu, orch"/><RxNorm RxCui="28031"/></Normalization></entity><entity charOffset="96:108" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.4" text="voriconazole" type="Drug"><Normalization><mmtx cui="C0393080" phraseText="voriconazole," preferredWord="voriconazole" semType="phsu, orch"/><RxNorm RxCui="121243"/></Normalization></entity><entity charOffset="110:119" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.5" text="ritonavir" type="Drug"><Normalization><mmtx cui="C0292818" phraseText="ritonavir," preferredWord="Ritonavir" semType="phsu, orch"/><RxNorm RxCui="85762"/></Normalization></entity><entity charOffset="121:135" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.6" text="clarithromycin" type="Drug"><Normalization><mmtx cui="C0055856" phraseText="clarithromycin," preferredWord="Clarithromycin" semType="orch, antb"/><RxNorm RxCui="21212"/></Normalization></entity><entity charOffset="141:151" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.7" text="nefazodone" type="Drug"><Normalization><mmtx cui="C0068485" phraseText="nefazodone" preferredWord="nefazodone" semType="phsu, orch"/><RxNorm RxCui="31565"/></Normalization></entity><entity charOffset="155:170" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.8" text="contraindicated" type="Caution_Interaction"/><entity charOffset="155:170" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.15" text="contraindicated" type="SPAN"/><entity charOffset="191:202" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.16" text="dronedarone" type="Drug"><Normalization><mmtx cui="C0766326" phraseText="exposure to dronedarone" preferredWord="dronedarone" semType="phsu, orch"/><RxNorm RxCui="233698"/></Normalization></entity><entity charOffset="179:187|203:229" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.17" text="exposure is significantly increased" type="Increase_Interaction"/><drugClassMembership drug="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.0" drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.1"/><drugClassMembership drug="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.2" drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.1"/><drugClassMembership drug="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.4" drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.1"/><drugClassMembership drug="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.5" drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.1"/><drugClassMembership drug="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.6" drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.1"/><drugClassMembership drug="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.7" drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.1"/><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.8"><relations><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.16"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.1"/></relation><relation type="hasSeverity"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.15"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.ddi.2"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.17"><relations><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.16"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.1" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.16" severity="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.15" trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.83.e.8" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.85" lineNumber="106" text="Patients should avoid grapefruit juice beverages while taking MULTAQ because exposure to dronedarone is significantly increased [see Clinical Pharmacology (12.3)]." type="regular"><anaphoraRelation><anaphoraEntity charOffset="89:100" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.85.e.4" text="dronedarone" type="Drug"/><antecedentEntity charOffset="62-68" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.85.e.1" text="MULTAQ" type="Drug"/></anaphoraRelation><entity charOffset="22:38" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.85.e.0" text="grapefruit juice" type="Substance"><Normalization><mmtx cui="C0440280" phraseText="grapefruit juice beverages" preferredWord="GRAPEFRUIT EXTRACT" semType="phsu, orch"/><RxNorm RxCui="124323"/></Normalization></entity><entity charOffset="62:68" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.85.e.1" text="MULTAQ" type="Drug"><Normalization><mmtx cui="C1744304" phraseText="taking MULTAQ" preferredWord="Multaq" semType="phsu, orch"/><RxNorm RxCui="677229"/></Normalization></entity><entity charOffset="77:85|101:127" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.85.e.2" text="exposure is significantly increased" type="Increase_Interaction"/><entity charOffset="89:100" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.85.e.4" text="dronedarone" type="Drug"><Normalization><mmtx cui="C0766326" phraseText="exposure to dronedarone" preferredWord="dronedarone" semType="phsu, orch"/><RxNorm RxCui="233698"/></Normalization></entity><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.85.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.85.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.85.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.85.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.85.e.0" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.85.e.4" trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.85.e.2" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="7" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.87" lineNumber="110" text="Avoid rifampin or other CYP 3A inducers such as phenobarbital, carbamazepine, phenytoin, and St John's wort because they decrease exposure to dronedarone significantly [see Clinical Pharmacology (12.3)]." type="regular"><entity charOffset="6:14" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.87.e.0" text="rifampin" type="Drug"><Normalization><mmtx cui="C0035608" phraseText="rifampin" preferredWord="Rifampin" semType="orch, antb"/><RxNorm RxCui="9384"/></Normalization></entity><entity charOffset="24:39" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.87.e.1" text="CYP 3A inducers" type="Drug_Class"><Normalization><RxNorm RxCui="24493"/></Normalization></entity><entity charOffset="48:61" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.87.e.3" text="phenobarbital" type="Drug"><Normalization><mmtx cui="C0031412" phraseText="other CYP 3A inducers such as phenobarbital," preferredWord="Phenobarbital" semType="phsu, orch"/><RxNorm RxCui="8134"/></Normalization></entity><entity charOffset="63:76" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.87.e.4" text="carbamazepine" type="Drug"><Normalization><mmtx cui="C0006949" phraseText="carbamazepine," preferredWord="Carbamazepine" semType="phsu, orch"/><RxNorm RxCui="2002"/></Normalization></entity><entity charOffset="78:87" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.87.e.5" text="phenytoin" type="Drug"><Normalization><mmtx cui="C0031507" phraseText="phenytoin," preferredWord="Phenytoin" semType="phsu, orch"/><RxNorm RxCui="8183"/></Normalization></entity><entity charOffset="93:107" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.87.e.6" text="St John's wort" type="Drug"><Normalization><mmtx cui="C0813171" phraseText="St John's wort" preferredWord="ST. JOHN'S WORT EXTRACT" semType="phsu, orch"/><RxNorm RxCui="669620"/></Normalization></entity><entity charOffset="142:153" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.87.e.11" text="dronedarone" type="Drug"><Normalization><mmtx cui="C0766326" phraseText="exposure to dronedarone significantly" preferredWord="dronedarone" semType="phsu, orch"/><RxNorm RxCui="233698"/></Normalization></entity><entity charOffset="121:138|154:167" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.87.e.12" text="decrease exposure significantly" type="Decrease_Interaction"/><drugClassMembership drug="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.87.e.0" drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.87.e.1"/><drugClassMembership drug="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.87.e.3" drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.87.e.1"/><drugClassMembership drug="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.87.e.4" drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.87.e.1"/><drugClassMembership drug="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.87.e.5" drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.87.e.1"/><drugClassMembership drug="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.87.e.6" drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.87.e.1"/><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.87.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.87.e.12"><relations><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.87.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.87.e.11"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.87.e.1" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.87.e.11" trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.87.e.12" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.89" lineNumber="114" text="Verapamil and diltiazem are moderate CYP 3A inhibitors and increase dronedarone exposure. " type="regular"><entity charOffset="28:54" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.89.e.0" text="moderate CYP 3A inhibitors" type="Drug_Class"><Normalization><RxNorm RxCui="855444"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.89.e.1" text="Verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="Verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="14:23" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.89.e.2" text="diltiazem" type="Drug"><Normalization><mmtx cui="C0012373" phraseText="diltiazem" preferredWord="Diltiazem" semType="phsu, orch"/><RxNorm RxCui="203211"/></Normalization></entity><entity charOffset="59:67|80:88" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.89.e.5" text="increase exposure" type="Increase_Interaction"/><entity charOffset="68:79" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.89.e.7" text="dronedarone" type="Drug"><Normalization><mmtx cui="C0766326" phraseText="increase dronedarone exposure." preferredWord="dronedarone" semType="phsu, orch"/><RxNorm RxCui="233698"/></Normalization></entity><drugClassMembership drug="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.89.e.1" drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.89.e.0"/><drugClassMembership drug="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.89.e.2" drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.89.e.0"/><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.89.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.89.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.89.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.89.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.89.e.7"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.89.e.2" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.89.e.7" trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.89.e.5" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.89.e.1" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.89.e.7" trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.89.e.5" type="Increase_Interaction"/><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.89.e.1" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.89.e.2"/></sentence><sentence biomedicalEntities="1" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.90" lineNumber="114" text="Give a low dose of calcium channel blockers initially and increase only after ECG verification of good tolerability [see Drug Interactions (7.3), Clinical Pharmacology (12.3)]." type="irregular"><entity charOffset="0:15" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.90.e.0" text="Give a low dose" type="Caution_Interaction"/><entity charOffset="19:43" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.90.e.2" text="calcium channel blockers" type="Drug_Class"><Normalization><mmtx cui="C0006684" phraseText="a low dose of calcium channel blockers initially" preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.90.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.90.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.90.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.89" text="Verapamil and diltiazem are moderate CYP 3A inhibitors and increase dronedarone exposure. "><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.89.e.7"/></ellipsisSentence></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.90.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.93" lineNumber="120" text="Dronedarone increased simvastatin/simvastatin acid exposure. " type="regular"><entity charOffset="0:11" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.93.e.0" text="Dronedarone" type="Drug"><Normalization><mmtx cui="C0766326" phraseText="Dronedarone increased simvastatin/simvastatin acid exposure." preferredWord="dronedarone" semType="phsu, orch"/><RxNorm RxCui="233698"/></Normalization></entity><entity charOffset="22:33" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.93.e.1" text="simvastatin" type="Drug"><Normalization><mmtx cui="C0246012" phraseText="Dronedarone increased simvastatin/simvastatin acid exposure." preferredWord="simvastatin acid" semType="phsu, orch"/><RxNorm RxCui="36567"/></Normalization></entity><entity charOffset="12:21|51:59" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.93.e.2" text="increased exposure" type="Increase_Interaction"/><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.93.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.93.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.93.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.93.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.93.e.0" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.93.e.1" trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.93.e.2" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.94" lineNumber="120" text="Avoid doses greater than 10 mg once daily of simvastatin [see Clinical Pharmacology (12.3)]." type="irregular"><entity charOffset="0:11" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.94.e.0" text="Avoid doses" type="Caution_Interaction"/><entity charOffset="45:56" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.94.e.2" text="simvastatin" type="Drug"><Normalization><mmtx cui="C0074554" phraseText="once daily of simvastatin" preferredWord="Simvastatin" semType="phsu, orch"/><RxNorm RxCui="36567"/></Normalization></entity><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.94.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.94.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.93" text="Dronedarone increased simvastatin/simvastatin acid exposure. "><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.93.e.0"/></ellipsisSentence></relation><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.94.e.2"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="6" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.96" lineNumber="124" text="Because of multiple mechanisms of interaction with statins (CYPs and transporters), follow statin label recommendations for use with CYP 3A and P-gp inhibitors such as dronedarone." type="regular"><anaphoraRelation><anaphoraEntity charOffset="91:97" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.96.e.11" text="statin" type="Expression"/><antecedentEntity charOffset="51-58" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.96.e.0" text="statins" type="Drug_Class"/></anaphoraRelation><entity charOffset="51:58" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.96.e.0" text="statins" type="Drug_Class"><Normalization><mmtx cui="C0360714" phraseText="with statins" preferredWord="Hydroxymethylglutaryl-CoA Reductase Inhibitors" semType="phsu, orch"/><RxNorm RxCui="108229"/></Normalization></entity><entity charOffset="60:64" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.96.e.1" text="CYPs" type="Drug_Class"><Normalization><RxNorm RxCui="24493"/></Normalization></entity><entity charOffset="69:81" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.96.e.2" text="transporters" type="Drug_Class"><Normalization><RxNorm RxCui="270009"/></Normalization></entity><entity charOffset="133:159" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.96.e.5" text="CYP 3A and P-gp inhibitors" type="Drug_Class"><Normalization><RxNorm RxCui="24493"/></Normalization></entity><entity charOffset="168:179" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.96.e.6" text="dronedarone" type="Drug"><Normalization><mmtx cui="C0766326" phraseText="P-gp inhibitors such as dronedarone." preferredWord="dronedarone" semType="phsu, orch"/><RxNorm RxCui="233698"/></Normalization></entity><entity charOffset="84:90|98:119" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.96.e.8" text="follow label recommendations" type="Caution_Interaction"/><entity charOffset="91:97" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.96.e.10" text="statin" type="Drug_Class"><Normalization><mmtx cui="C0360714" phraseText="statin label recommendations for use" preferredWord="Hydroxymethylglutaryl-CoA Reductase Inhibitors" semType="phsu, orch"/><RxNorm RxCui="108229"/></Normalization></entity><classClassMembership drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.96.e.1"/><classClassMembership drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.96.e.2"/><drugClassMembership drug="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.96.e.6" drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.96.e.5"/><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.96.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.96.e.8"><relations><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.96.e.6"/></relation><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.96.e.10"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.96.e.10" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.96.e.6" trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.96.e.8" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="5" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.98" lineNumber="128" text="Dronedarone increased the exposure of calcium channel blockers (verapamil, diltiazem or nifedipine). " type="regular"><entity charOffset="0:11" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.98.e.0" text="Dronedarone" type="Drug"><Normalization><mmtx cui="C0766326" phraseText="Dronedarone" preferredWord="dronedarone" semType="phsu, orch"/><RxNorm RxCui="233698"/></Normalization></entity><entity charOffset="38:62" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.98.e.1" text="calcium channel blockers" type="Drug_Class"><Normalization><mmtx cui="C0006684" phraseText="the exposure of calcium channel blockers" preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="64:73" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.98.e.2" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="(verapamil," preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="75:84" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.98.e.3" text="diltiazem" type="Drug"><Normalization><mmtx cui="C0012373" phraseText="diltiazem" preferredWord="Diltiazem" semType="phsu, orch"/><RxNorm RxCui="203211"/></Normalization></entity><entity charOffset="88:98" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.98.e.4" text="nifedipine" type="Drug"><Normalization><mmtx cui="C0028066" phraseText="nifedipine" preferredWord="Nifedipine" semType="phsu, orch"/><RxNorm RxCui="7417"/></Normalization></entity><entity charOffset="12:34" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.98.e.8" text="increased the exposure" type="Increase_Interaction"/><drugClassMembership drug="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.98.e.2" drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.98.e.1"/><drugClassMembership drug="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.98.e.3" drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.98.e.1"/><drugClassMembership drug="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.98.e.4" drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.98.e.1"/><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.98.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.98.e.8"><relations><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.98.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.98.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.98.e.0" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.98.e.1" trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.98.e.8" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.99" lineNumber="128" text="Give a low dose of calcium channel blockers initially and increase only after ECG verification of good tolerability [see Drug Interactions (7.1), Clinical Pharmacology (12.3)]." type="irregular"><entity charOffset="0:15" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.99.e.0" text="Give a low dose" type="Caution_Interaction"/><entity charOffset="19:43" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.99.e.2" text="calcium channel blockers" type="Drug_Class"><Normalization><mmtx cui="C0006684" phraseText="a low dose of calcium channel blockers initially" preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.99.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.99.e.0"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.98" text="Dronedarone increased the exposure of calcium channel blockers (verapamil, diltiazem or nifedipine). "><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.98.e.0"/></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.99.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.99.e.2"/></sentence><sentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.100" text="Sirolimus, tacrolimus, and other CYP3A substrates with narrow therapeutic range" type="negative"><entity charOffset="11:21" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.100.e.0" text="tacrolimus" type="Biomedical_Entity"><Normalization><mmtx cui="C0085149" phraseText="tacrolimus," preferredWord="Tacrolimus" semType="phsu, orch"/><RxNorm RxCui="42316"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.100.e.1" text="sirolimus" type="Biomedical_Entity"><Normalization><mmtx cui="C0072980" phraseText="Sirolimus," preferredWord="Sirolimus" semType="orch, antb"/><RxNorm RxCui="35302"/></Normalization></entity><pair ddi="false" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.100.e.1" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.100.e.0"/></sentence><sentence biomedicalEntities="4" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.101" lineNumber="132" text="Dronedarone can increase plasma concentrations of tacrolimus, sirolimus, and other CYP 3A substrates with a narrow therapeutic range when given orally. " type="regular"><entity charOffset="0:11" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.101.e.0" text="Dronedarone" type="Drug"><Normalization><mmtx cui="C0766326" phraseText="Dronedarone" preferredWord="dronedarone" semType="phsu, orch"/><RxNorm RxCui="233698"/></Normalization></entity><entity charOffset="83:132" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.101.e.1" text="CYP 3A substrates with a narrow therapeutic range" type="Drug_Class"><Normalization><RxNorm RxCui="24493"/></Normalization></entity><entity charOffset="50:60" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.101.e.2" text="tacrolimus" type="Drug"><Normalization><mmtx cui="C0085149" phraseText="plasma concentrations of tacrolimus," preferredWord="Tacrolimus" semType="phsu, orch"/><mmtx cui="C0085149" phraseText="plasma concentrations of tacrolimus," preferredWord="Tacrolimus" semType="phsu, orch"/><RxNorm RxCui="42316"/></Normalization></entity><entity charOffset="62:71" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.101.e.3" text="sirolimus" type="Drug"><Normalization><mmtx cui="C0072980" phraseText="sirolimus," preferredWord="Sirolimus" semType="orch, antb"/><RxNorm RxCui="35302"/></Normalization></entity><entity charOffset="16:46" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.101.e.6" text="increase plasma concentrations" type="Increase_Interaction"/><drugClassMembership drug="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.101.e.3" drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.101.e.1"/><drugClassMembership drug="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.101.e.2" drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.101.e.1"/><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.101.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.101.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.101.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.101.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.101.e.0" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.101.e.1" trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.101.e.6" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="0" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.102" lineNumber="132" text="Monitor plasma concentrations and adjust dosage appropriately." type="irregular"><entity charOffset="0:7" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.102.e.0" text="Monitor" type="Caution_Interaction"/><entity charOffset="34:47" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.102.e.2" text="adjust dosage" type="Caution_Interaction"/><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.102.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.102.e.0"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.101" text="Dronedarone can increase plasma concentrations of tacrolimus, sirolimus, and other CYP 3A substrates with a narrow therapeutic range when given orally. "><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.101.e.0"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.101" text="Dronedarone can increase plasma concentrations of tacrolimus, sirolimus, and other CYP 3A substrates with a narrow therapeutic range when given orally. "><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.101.e.1"/></ellipsisSentence></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.102.ddi.2"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.102.e.2"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.101" text="Dronedarone can increase plasma concentrations of tacrolimus, sirolimus, and other CYP 3A substrates with a narrow therapeutic range when given orally. "><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.101.e.0"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.101" text="Dronedarone can increase plasma concentrations of tacrolimus, sirolimus, and other CYP 3A substrates with a narrow therapeutic range when given orally. "><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.101.e.1"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="3" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.104" lineNumber="136" text="Dronedarone increased the exposure of propranolol and metoprolol. " type="regular"><entity charOffset="0:11" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.104.e.0" text="Dronedarone" type="Drug"><Normalization><mmtx cui="C0766326" phraseText="Dronedarone" preferredWord="dronedarone" semType="phsu, orch"/><RxNorm RxCui="233698"/></Normalization></entity><entity charOffset="38:49" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.104.e.1" text="propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="the exposure of propranolol" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="54:64" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.104.e.2" text="metoprolol" type="Drug"><Normalization><mmtx cui="C0025859" phraseText="metoprolol." preferredWord="Metoprolol" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><entity charOffset="12:34" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.104.e.3" text="increased the exposure" type="Increase_Interaction"/><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.104.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.104.e.3"><relations><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.104.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.104.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.104.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.104.e.0" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.104.e.2" trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.104.e.3" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.104.e.0" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.104.e.1" trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.104.e.3" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.105" lineNumber="136" text="Give low doses of beta-blockers initially, and increase only after ECG verification of good tolerability. " type="irregular"><entity charOffset="0:14" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.105.e.0" text="Give low doses" type="Caution_Interaction"/><entity charOffset="18:31" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.105.e.2" text="beta-blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="low doses of beta-blockers initially," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.105.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.105.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.105.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.104" text="Dronedarone increased the exposure of propranolol and metoprolol. "><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.104.e.0"/></ellipsisSentence></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.105.e.2"/></sentence><sentence biomedicalEntities="5" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.106" lineNumber="136" text="Other CYP 2D6 substrates, including other beta-blockers, tricyclic antidepressants, and selective serotonin reuptake inhibitors (SSRIs) may have increased exposure upon co-administration with dronedarone [see Drug Interactions (7.1), Clinical Pharmacology (12.3)]." type="regular"><entity charOffset="6:24" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.106.e.0" text="CYP 2D6 substrates" type="Drug_Class"><Normalization><RxNorm RxCui="24493"/></Normalization></entity><entity charOffset="42:55" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.106.e.1" text="beta-blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="other beta-blockers," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="57:82" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.106.e.2" text="tricyclic antidepressants" type="Drug_Class"><Normalization><mmtx cui="C0003290" phraseText="tricyclic antidepressants," preferredWord="Tricyclic Antidepressive Agents" semType="phsu"/><RxNorm RxCui="928"/></Normalization></entity><entity charOffset="88:135" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.106.e.3" text="selective serotonin reuptake inhibitors (SSRIs)" type="Drug_Class"><Normalization><mmtx cui="C0360105" phraseText="selective serotonin reuptake inhibitors (SSRIs)" preferredWord="Selective Serotonin Reuptake Inhibitors" semType="phsu"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="145:163" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.106.e.7" text="increased exposure" type="Increase_Interaction"/><entity charOffset="192:203" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.106.e.9" text="dronedarone" type="Drug"><Normalization><mmtx cui="C0766326" phraseText="with dronedarone" preferredWord="dronedarone" semType="phsu, orch"/><RxNorm RxCui="233698"/></Normalization></entity><classClassMembership drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.106.e.1"/><classClassMembership drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.106.e.2"/><classClassMembership drugClass="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.106.e.3"/><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.106.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.106.e.7"><relations><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.106.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.106.e.9"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.106.e.0" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.106.e.9" trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.106.e.7" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.109" lineNumber="142" text="Dronedarone increased digoxin exposure by inhibiting the P-gp transporter. " type="regular"><entity charOffset="0:11" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.109.e.0" text="Dronedarone" type="Drug"><Normalization><mmtx cui="C0766326" phraseText="Dronedarone increased digoxin exposure by inhibiting" preferredWord="dronedarone" semType="phsu, orch"/><RxNorm RxCui="233698"/></Normalization></entity><entity charOffset="22:29" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.109.e.1" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="Dronedarone increased digoxin exposure by inhibiting" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="12:21|30:38" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.109.e.2" text="increased exposure" type="Increase_Interaction"/><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.109.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.109.e.2"><relations><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.109.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.109.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.109.e.0" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.109.e.1" trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.109.e.2" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.110" lineNumber="142" text="Consider discontinuing digoxin. " type="irregular"><entity charOffset="9:22" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.110.e.0" text="discontinuing" type="Caution_Interaction"/><entity charOffset="23:30" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.110.e.2" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="discontinuing digoxin." preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.110.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.110.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.110.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.109" text="Dronedarone increased digoxin exposure by inhibiting the P-gp transporter. "><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.109.e.0"/></ellipsisSentence></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.110.e.2"/></sentence><sentence biomedicalEntities="1" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.111" lineNumber="142" text="If digoxin treatment is continued, halve the dose of digoxin, monitor serum levels closely, and observe for toxicity [see Drug Interactions (7.1), Clinical Pharmacology (12.3)]." type="irregular"><entity charOffset="35:49" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.111.e.0" text="halve the dose" type="Caution_Interaction"/><entity charOffset="53:60" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.111.e.2" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="the dose of digoxin," preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="62:69" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.111.e.3" text="monitor" type="Caution_Interaction"/><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.111.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.111.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.109" text="Dronedarone increased digoxin exposure by inhibiting the P-gp transporter. "><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.109.e.0"/></ellipsisSentence><middleSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.110" text="Consider discontinuing digoxin. "/></relation><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.111.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.111.ddi.2"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.111.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.111.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.109" text="Dronedarone increased digoxin exposure by inhibiting the P-gp transporter. "><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.109.e.0"/></ellipsisSentence><middleSentence id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.110" text="Consider discontinuing digoxin. "/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.113" lineNumber="146" text="Exposure to dabigatran is higher when it is administered with dronedarone than when it is administered alone." type="regular"><entity charOffset="12:22" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.113.e.0" text="dabigatran" type="Drug"><Normalization><mmtx cui="C2348066" phraseText="Exposure to dabigatran" preferredWord="dabigatran" semType="phsu"/><RxNorm RxCui="814696"/></Normalization></entity><entity charOffset="0:8|23:32" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.113.e.1" text="Exposure is higher" type="Increase_Interaction"/><entity charOffset="62:73" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.113.e.3" text="dronedarone" type="Drug"><Normalization><mmtx cui="C0766326" phraseText="administered with dronedarone" preferredWord="dronedarone" semType="phsu, orch"/><RxNorm RxCui="233698"/></Normalization></entity><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.113.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.113.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.113.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.113.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.113.e.0" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.113.e.3" trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.113.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.114" lineNumber="148" text="Other P-gp substrates are expected to have increased exposure when co-administered with dronedarone." type="regular"><entity charOffset="6:21" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.114.e.0" text="P-gp substrates" type="Drug_Class"><Normalization><RxNorm RxCui="71576"/></Normalization></entity><entity charOffset="43:61" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.114.e.1" text="increased exposure" type="Increase_Interaction"/><entity charOffset="88:99" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.114.e.3" text="dronedarone" type="Drug"><Normalization><mmtx cui="C0766326" phraseText="co-administered with dronedarone." preferredWord="dronedarone" semType="phsu, orch"/><RxNorm RxCui="233698"/></Normalization></entity><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.114.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.114.e.1"><relations><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.114.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.114.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.114.e.0" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.114.e.3" trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.114.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.116" lineNumber="152" text="When co-administered with dronedarone exposure to S-warfarin was slightly higher than when warfarin was administered alone. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="91:99" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.116.e.2" text="warfarin" type="Drug"/><antecedentEntity charOffset="50-60" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.116.e.1" text="S-warfarin" type="Drug"/></anaphoraRelation><entity charOffset="26:37" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.116.e.0" text="dronedarone" type="Drug"><Normalization><mmtx cui="C0766326" phraseText="co-administered with dronedarone exposure to S-warfarin" preferredWord="dronedarone" semType="phsu, orch"/><RxNorm RxCui="233698"/></Normalization></entity><entity charOffset="50:60" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.116.e.1" text="S-warfarin" type="Drug"><Normalization><mmtx cui="C0043031" phraseText="co-administered with dronedarone exposure to S-warfarin" preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="91:99" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.116.e.2" text="warfarin" type="Drug"><Normalization><mmtx cui="C0043031" phraseText="warfarin" preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="38:46|61:80" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.116.e.4" text="exposure was slightly higher" type="Increase_Interaction"/><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.116.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.116.e.4"><relations><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.116.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.116.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.116.e.0" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.116.e.1" trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.116.e.4" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.118" lineNumber="154" text="More patients experienced clinically significant INR elevations (  5) usually within 1 week after starting dronedarone vs. placebo in patients taking oral anticoagulants in ATHENA. " type="regular"><entity charOffset="49:63" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.118.e.0" text="INR elevations" type="Specific_Interaction"/><entity charOffset="107:118" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.118.e.2" text="dronedarone" type="Drug"><Normalization><mmtx cui="C0766326" phraseText="after starting dronedarone" preferredWord="dronedarone" semType="phsu, orch"/><RxNorm RxCui="233698"/></Normalization></entity><entity charOffset="150:169" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.118.e.3" text="oral anticoagulants" type="Drug_Class"><Normalization><mmtx cui="C0354604" phraseText="oral anticoagulants in ATHENA." preferredWord="Anticoagulants, Oral" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.118.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.118.e.0"><relations><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.118.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.118.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.118.e.2" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.118.e.3" trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.118.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.120" lineNumber="156" text="Postmarketing cases of increased INR with or without bleeding events have been reported in warfarin-treated patients initiated on dronedarone. " type="regular"><entity charOffset="23:41|53:68" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.120.e.0" text="increased INR with bleeding events" type="Specific_Interaction"/><entity charOffset="23:36|45:68" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.120.e.2" text="increased INR without bleeding events" type="Specific_Interaction"/><entity charOffset="91:99" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.120.e.4" text="warfarin" type="Drug"><Normalization><mmtx cui="C0043031" phraseText="reported in warfarin-treated patients" preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="130:141" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.120.e.5" text="dronedarone" type="Drug"><Normalization><mmtx cui="C0766326" phraseText="initiated on dronedarone." preferredWord="dronedarone" semType="phsu, orch"/><RxNorm RxCui="233698"/></Normalization></entity><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.120.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.120.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.120.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.120.e.5"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.120.ddi.2"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.120.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.120.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.120.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.120.e.4" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.120.e.5" trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.120.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.121" lineNumber="156" text="Monitor INR after initiating dronedarone in patients taking warfarin." type="regular"><entity charOffset="0:7" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.121.e.0" text="Monitor" type="Caution_Interaction"/><entity charOffset="29:40" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.121.e.2" text="dronedarone" type="Drug"><Normalization><mmtx cui="C0766326" phraseText="Monitor INR after initiating dronedarone" preferredWord="dronedarone" semType="phsu, orch"/><RxNorm RxCui="233698"/></Normalization></entity><entity charOffset="60:68" id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.121.e.3" text="warfarin" type="Drug"><Normalization><mmtx cui="C0043031" phraseText="warfarin." preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><drugInteraction id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.121.ddi.1"><interaction trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.121.e.0"><relations><relation type="hasObject"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.121.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.121.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.121.e.2" e2="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.121.e.3" trigger="Dailymed.7fa41601-7fb5-4155-8e50-2ae903f0d2d6.s.121.e.0" type="Caution_Interaction"/></sentence><positiveExamples number="33"/><negativeExamples number="37"/></document>